[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fxLN3MUwXCdr5RPjwZYIDpOj8CHyjOmngWTgoKXPtZbg":3,"$fuG3Z1m2sKrbsKyRL5ymXXhfj10h2t1SYNIekLRv3cZg":32,"$f3Ft0rKFJHppdzE-vuveecxx1BUcg9iOlMLtyzf_MJDg":60},[4,8,12,16,20,24,28],{"title":5,"slug":6,"path":7},"About Microbeonline.com","about-microbeonline-com","\u002Fabout-microbeonline-com\u002F",{"title":9,"slug":10,"path":11},"About Me","about-me","\u002Fabout-microbeonline-com\u002Fabout-me\u002F",{"title":13,"slug":14,"path":15},"Advertise with Us","advertise-us","\u002Fadvertise-us\u002F",{"title":17,"slug":18,"path":19},"Privacy Policy","privacy-policy","\u002Fprivacy-policy\u002F",{"title":21,"slug":22,"path":23},"Abbreviations","abbreviations","\u002Fabbreviations\u002F",{"title":25,"slug":26,"path":27},"Microbes","microbes","\u002Fmicrobes\u002F",{"title":29,"slug":30,"path":31},"Books","recommended-books","\u002Frecommended-books\u002F",{"type":33,"data":34},"blog",{"slug":35,"title":36,"description":37,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":40,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"body":44,"faq":45,"tags":58,"related":59},"laboratory-diagnosis-of-hepatitis-a-virus","Hepatitis A Virus: Why It Spreads Fast But Never Becomes Chronic","How HAV's bare, acid-resistant capsid drives outbreaks through food and water, and why it never causes chronic infection unlike B or C.",null,"Ashma Shrestha","2022-04-27","2026-07-01",false,"virology","A cluster of college hostel residents develop fever and dark urine within the same week, traced back to a shared water tank contaminated weeks earlier. None of them recall feeling sick around the time of exposure; the outbreak only became visible once jaundice appeared, by which point most of them had already stopped shedding virus in their stool.\n\nWhy would a virus design itself to be most contagious *before* anyone looks sick? The answer is in the capsid. HAV has no envelope at all, just a bare, stable protein shell, which sounds like a structural weakness until you consider what that shell has to survive: stomach acid, bile salts, and detergent-like conditions in the gut, all of which would tear apart an enveloped virus like HBV or HCV in seconds. An envelope is a liability in this environment; a tough, naked capsid is the adaptation that lets HAV travel through a hostile gut, get absorbed, and reach the liver intact via the fecal-oral route. The same toughness, incidentally, is exactly why HAV survives in contaminated water long enough to start outbreaks like the one above.\n\nAnd once you understand that HAV is purely an acute, self-limited liver infection, never chronic, you understand why the public health response to that hostel outbreak looks completely different from how a hospital would respond to a needlestick exposure to hepatitis B. There's no carrier state to screen for afterward, no lifelong infection to monitor. The entire clinical story here is about the days to weeks immediately surrounding exposure, which is exactly where this article's diagnostic timing and post-exposure prophylaxis sections earn their importance.\n\nInflammation of hepatocytes (liver cells) is termed hepatitis. The major cause of hepatitis is a viral infection but other causes include excessive consumption of alcohol, toxins, different medications, and autoimmune disorders.\n\nHepatitis can be classified based on transmissibility into two classes:\n\n1. **Infectious (viral hepatitis)**: These include acute hepatitis caused by hepatitis viruses A, B, C, D, and E, and chronic infection by hepatitis B, hepatitis C, and hepatitis D viruses. (Hepatitis G virus, also known as GBV-C, has been described but is not confirmed to cause clinically significant liver disease and is generally excluded from current classifications.)\n2. **Non-infectious**: Usually, this infection is caused by autoimmune disorders, excessive alcohol consumption, medications, and ingestion of toxins.\n\nHepatitis A is a fecal-oral transmitted infection often acquired through contaminated food and water. Hepatitis A virus (HAV) causes infectious hepatitis. It is an acute, self-limited disease of global distribution, which affects mainly children and young adults.\n\n## Morphology of Hepatitis A Virus\n\n- HAV is a small (about 27nm) and non-enveloped virus\n- It consists of single-stranded positive RNA viruses\n- It also consists stable capsid proteins\n\n![Structure of Hepatitis A](https:\u002F\u002Flh5.googleusercontent.com\u002Fmay-0oEDTzgO9Jatt5WawJArG8B8VAmRqUiF-ecOSSPbD1cRM3h6Pgy10Yoz2FAidOz3p1TNjIqhJSbAQJIwAp6waDGzdy8H9BImscvRMB3KGh7md2yA519RO-H0SDR1cL8QJkuf)Figure: Structure of Hepatitis A\n\n**Genomic arrangements**\n\n- The genome of hepatitis A virus is single-stranded 7.5kb long with positive polarity (positive sense).\n- The organization is similar to other picornaviruses\n- Has a very low G+C concentration compared to other picornaviruses.\n- The 5’ end is not capped but linked to a viral protein Vpg which is the primer for protein synthesis.\n- Most studied genomic strain HM175 suggests that the genome contains only 1 open reading frame flanked by a comparatively long nucleotide sequence of 735 at 5’UTR end and a short 63 nucleotide sequence at 3’UTR end.\n- Both UTR segments consisted of the remarkable secondary structure of RNA which was identified with the help of different mapping sites.\n- Furthermore, the 3’side of the RNA comprises complex structural elements which play the role of the internal ribosome entry site. (IRES) and helps in cap-independent translation of HAV protein.\n\n![Genomic arrangement of HAV](https:\u002F\u002Flh5.googleusercontent.com\u002FAQClVFan0tUL2XlVMkTtwSDE8J4yyjuiWMASJAHCl6Z4Ctbay8NoaDXyd3-myc_EDsiMpI0hf8NyBtH8v4j9dVemzy8Uyl9bIytf0kyk5McvxS1op-iIqk51xUT_qKne-ZHvMZAp)Figure: Genomic arrangement of HAV\n\n## How to Remember\n\n**No envelope is the adaptation, not a missing feature.** Every fact under \"Virulence factors\" below, survival in harsh environments, resistance to detergents and ether, makes sense once you see the naked capsid as armor built specifically for surviving the gut, not as a virus that simply \"forgot\" to acquire an envelope the way HBV and HCV did. Enveloped viruses are fragile outside the body and outside cells; HAV's whole transmission strategy depends on the opposite property.\n\n**\"Acute only, never chronic\" is the single fact that separates HAV from B, C, and D.** A simple way to hold this: among the five hepatitis viruses, only the ones that establish a way to persist quietly inside cells (B, C, D, through mechanisms like cccDNA persistence or rapid antigenic variation) become chronic. HAV does neither, the immune system clears it completely, usually within weeks, and the person is left with lifelong immunity rather than a carrier state. If an exam question describes a hepatitis virus with \"chronic carrier state\" or \"risk of hepatocellular carcinoma from persistent infection,\" it is testing you on B, C, or D, never A.\n\n**Shedding peaks before symptoms, which is the opposite of what most students assume.** It's tempting to think the sickest-looking phase of an infection is also the most contagious one. For HAV, virus shedding in stool is highest in the 1-2 weeks *before* jaundice appears, and the person typically becomes noncontagious once jaundice is visible. This single timing fact explains why outbreaks spread silently through shared food or water before anyone realizes there's a problem, and why isolating visibly jaundiced patients does little to stop ongoing transmission from people who were infectious earlier and already look fine.\n\n## Replication of Hepatitis A Virus\n\n### Cell entry\n\n- Entry of the virus into cells is from ingestion of the virus. However, the cells that get infected first are a mystery.\n- One theory suggests that, although the virus is naked or non-enveloped a pseudo or quasi enveloped (eHAV) enters the liver cells with attachment to the TIM1 (T-Cell immunoglobulin and mucin domain protein 1) a phosphatidyl-serine receptor.\n- The receptor is now commonly known as HAVCR1 (HAV cellular receptor 1).\n- The binding facilitates the uncoating of the viral genome into the endosomal membranes.\n- The exact role of this receptor-binding mechanism in natural HAV infection is still not fully defined, though it is considered relevant to how efficiently the virus enters liver cells.\n- Another theory suggests entry via naked virion attaching to the same receptor, this is rapid as a lysosomal step of removing the envelope decreases.\n\n### Uncoating of viral material\n\nAfter the entry, the RNA genome is released inside the cell maybe along with the capsid.\n\n### Protein synthesis\n\n- Protein synthesis occurs as soon as the viral genome is released inside the cell.\n- Translation of both structural and non-structural proteins is necessary to start RNA replication.\n- VPg is removed from the RNA as soon as the release of the RNA. And translation is initiated at a 5’ cap-independent way controlled by IRES.\n- Then, the initiation of translation occurs at any one closely attached space of AUG codons resulting in a heterogenous VP4 sequence.\n- The IRES is type III which is different from other picornavirus and unlike other enteroviruses, these IRES elements do not shut down host mRNA translation instead both the translation run side by side.\n\n### RNA synthesis\n\n- Copying of a positive-strand into a minus strand occurs resulting in the formation of ds-RNA.\n- The minus strand is produced from the 3’ end of the genomic RNA primed at uridylated VPg.\n- The ds-RNA then helps in the production of new positive-strand genomes.\n- The production of positive-strand is similar to negative-strand production but the site is at uridylated VPg at 5’ end.\n\n### Virion assembly\n\nThe detailed process of assembly of viral particles is less known. But the location of assembly is at the plasma membrane of the host cell.\n\n![Replication of HAV](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002FReplication-of-HAV.png)Figure: Replication of HAV\n\n## Pathogenesis\n\n### Transmission\n\n- It is highly contagious. The transmission occurs through the fecal-oral route (water and food contaminated with feces of the infected person).\n- The reservoir is human beings. Excretion of virus occurs in the first 2 weeks of infection.\n- The infected person may be noncontagious after the appearance of jaundice.\n\n### Physical Properties and Environmental Resistance\n\n- Survival in extreme environmental conditions\n- Resistant to detergents and ethers\n\n### Incubation period\n\nThe average incubation period is about 4 weeks (28 days), with a range of approximately 15 to 50 days.\n\n- Replication begins from gastrointestinal sites and progresses down to liver cells.\n- Although the complete mechanism of destruction of hepatocytes by this virus is unknown. Some speculation suggests the involvement of Cytotoxic T-cells in damaging hepatocytes. It quickly heals after the complete removal of the infection.\n- Mononuclear infiltrate, swelling, degeneration, and acidophilic bodies is the result of infection in the hepatocytes which are similar to other viral hepatitis infections.\n- Usually, the infection is self-limiting after 2-4 weeks of infection, and once infected the person develops lifelong immunity.\n\n**Mortality rate**\n\nThe mortality rate of HAV infection is less than 0.01%.\n\n### Symptoms\n\n- Tiredness\n- Nausea\n- Vomiting\n- Fever\n- Hepatomegaly\n- Jaundice\n- Anorexia\n- Rash\n- Passing dark urine, and pale feces.\n\n## Where Students Get Confused\n\n**\"HAV can become chronic in some patients, like HBV does.\"** It cannot. This is the single most important contrast point across the hepatitis viruses, and exam questions frequently test it by describing a chronic carrier state or progression to cirrhosis\u002Fhepatocellular carcinoma, hoping students will assume this could describe any hepatitis virus. Only HBV, HCV, and HDV establish chronic infection; HAV (and HEV, in most cases) cause self-limited acute disease only.\n\n**\"A positive anti-HAV antibody test always means current infection.\"** It doesn't specify timing on its own. Total anti-HAV detects both IgM and IgG combined, so a positive total anti-HAV result with a negative IgM anti-HAV actually indicates past infection or vaccination, not an active infection, IgM anti-HAV is the marker that specifically confirms acute disease.\n\n**\"Giving immunoglobulin after exposure is pointless since the person is already infected.\"** It isn't pointless, because HAV's incubation period (averaging about 4 weeks) creates a real window before disease develops. Post-exposure immunoglobulin within 2 weeks of exposure can blunt or prevent clinical disease precisely because there's still time before the virus has caused enough liver damage to produce symptoms.\n\n## Laboratory diagnosis of HAV infection\n\n### Specimen\n\n- Stool (antigen detection) or serum (antibody detection) of the suspected patient.\n\n**Collection and Transport of Stool**\n\nCollect the stool in a sterile, leak-proof, and dry container. Preferred amount is 10cc\u002Fml of diarrheal sample. The patient is instructed to collect stool in sterile conditions. As per feasibility and transported to the laboratory within the first 1 hour of collection. If delayed, refrigeration at 4℃ or collection should be done in a container with a [viral transport medium](\u002Fviral-transport-media-vtm\u002F).\n\n**Collection and Transport of Blood for serum**\n\nA serum sample from the same patients is ideal for the correct diagnosis. Blood (15ml from adults and 3ml from children) is drawn aseptically in a tube without anticoagulant. [Centrifuge](\u002Fcentrifuge-parts-types-handling\u002F) the blood sample in 1000-2000g for 10 minutes. The separated serum sample is then processed. If there is a delay in processing the sample, refrigerate at 4℃ (do not freeze the sample).\n\n(NOTE: if centrifuge is not available, the blood is refrigerated until a clot is formed, the serum is then pipetted into an empty sterile tube and transported to the laboratory as soon as possible.)\n\n### Sample processing\n\nSample process is done by following ways:\n\n#### Microscopy\n\nAn [electron microscope](\u002Felectron-microscope-principle-types-applications\u002F) can detect viral material in the fecal matter of the suspected individuals.\n\n#### Virus Isolation\n\nAlthough virus isolation in human cell lines is possible, it is not applicable during routine diagnosis. But useful for research purposes.\n\n#### Antigen detection\n\n- Detection of the antigen (viral proteins) of hepatitis A in the stool and sera of the patients 2 weeks before the onset of jaundice to 2 weeks after the onset of jaundice using electron microscopy.\n- Similarly, radioimmunoassay and enzyme immunoassay have also helped in the detection of antigens in fecal matters, and cell culture.\n\n#### Serology\n\nHepatitis A cannot be distinguished from other types of viral hepatitis on the basis of clinical or epidemiologic features alone. Serology is the primary method for the laboratory diagnosis of hepatitis A virus (HAV) infection.\n\n![ - Timeline for Hepatitis A Virus Infection](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002FTimeline-for-Hepatitis-A-virus-Infection.jpg)Figure: Timeline for Hepatitis A Virus Infection\n\nIgM anti-HAV is the reliable marker of acute infection with hepatitis A virus. Virtually all patients with acute hepatitis A have detectable IgM anti-HAV. Laboratory testing for IgM anti-HAV is typically positive at the time of onset of symptoms (detectable 5\u002F6 days prior to the onset of symptoms). It remains positive for 3-6 months after primary infection. IgG antibodies on the other hand persist for life and indicate immunity against reinfection.\n\nThe antibody test for total anti-HAV measures both IgG anti-HAV and IgM anti-HAV. Persons who are total anti-HAV positive and IgM anti-HAV negative i.e. presence of IgG anti-HAV in the absence of IgM anti-HAV indicate past infection or vaccination rather than acute infection.\n\n#### Molecular Diagnosis\n\nDetection of the nucleic acid of HAV is done in the following ways:\n\n- Restriction fragment length polymorphism (RFLP)\n- [Southern blotting](\u002Fsouthern-blotting-principle-steps-and-applications\u002F)\n- Single-strand conformational polymorphism\n- Reverse transcription-PCR\n- Antigen capture RT-PCR\n\n**Other methods of detection of hepatitis:**\n\n- The test for the level of ALT (alanine aminotransferase) and AST (aspartate aminotransferase) in serum is highly useful for the detection of HAV infections as the infections trigger an increase in the level of ALT and AST before the onset of symptoms to 3-10 days after the onset of the symptoms\n- Similarly, monitoring serum bilirubin levels is also important. During the appearance of jaundice the level increases. And the decreased level of serum albumin level suggests a serious infection in hepatocytes.\n\n## Prevention and Control\n\nNo antiviral therapy is necessary only the treatment of symptoms is enough.\n\n**Vaccine**\n\nPreferably two doses of vaccine at the interval of 6-18 months. There was an anamnestic response when the second dose was taken after several years. Because of this, the timing of the second dose is very crucial.\n\n**Prophylaxis with immunoglobulin**\n\nPost-exposure immunoglobulin within 2 weeks is recommended in those who are in immediate contact with the infected patients.\n\nThe preferred way of administration is a dose of 0.02ml intramuscularly.\n\n**Preventing spread**\n\nThe best way to control the infection is to maintain the cleanliness of drinking water and food by regularly cleaning the water sources, avoiding raw foods, and maintaining personal hygiene.\n\n## Key Exam Facts Table\n\n| Feature | Detail |\n| --- | --- |\n| Family \u002F Genus | Picornaviridae \u002F Hepatovirus |\n| Genome | Positive-sense, single-stranded RNA, \\~7.5 kb |\n| Envelope | None (naked capsid), \\~27 nm |\n| Transmission | Fecal-oral (contaminated food\u002Fwater) |\n| Average incubation period | \\~4 weeks (range 15-50 days) |\n| Shedding window | Peaks 1-2 weeks before jaundice; declines once jaundice appears |\n| Chronicity | Never chronic; lifelong immunity after recovery |\n| Mortality | <0.01% |\n| Acute diagnostic marker | IgM anti-HAV |\n| Past infection\u002Fimmunity marker | IgG anti-HAV (Total anti-HAV positive, IgM anti-HAV negative) |\n| Post-exposure prophylaxis | Immunoglobulin within 2 weeks of exposure |\n| Vaccine schedule | 2 doses, 6-18 months apart |\n\n**References:**\n\n- Abutaleb, A., & Kottilil, S. (2020). Hepatitis A: Pathophysiology and treatment. *Gastroenterology Clinics of North America*, *49*(2), 209–220. \u003Chttps:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.gtc.2020.01.001>\n- McKnight, K. L., & Lemon, S. M. (2018). Hepatitis A virus genome organization and replication strategy. *Cold Spring Harbor Perspectives in Medicine*, *8*(12), a033480. \u003Chttps:\u002F\u002Fdoi.org\u002F10.1101\u002Fcshperspect.a033480>\n- Nainan, O. V., Xia, G., Vaughan, G., & Margolis, H. S. (2006). Diagnosis of hepatitis A virus infection: a molecular approach. *Clinical Microbiology Reviews*, *19*(1), 63–79. \u003Chttps:\u002F\u002Fdoi.org\u002F10.1128\u002FCMR.19.1.63-79.2006>\n- Parija, S. C. (2012). *Textbook of Microbiology and Immunology* (2nd ed.). Elsevier.",[46,49,52,55],{"question":47,"answer":48},"Can hepatitis A become a chronic infection like hepatitis B?","No. HAV causes only acute, self-limited disease. The immune system clears the virus completely, typically within a few weeks, and the person develops lifelong immunity. Chronic infection is a feature of hepatitis B, C, and D, not A.",{"question":50,"answer":51},"If someone already feels fine after a hepatitis A exposure, is it too late for prevention?","Not necessarily. HAV has an average incubation period of about 4 weeks before symptoms appear, so post-exposure immunoglobulin given within 2 weeks of exposure can still prevent or reduce the severity of disease.",{"question":53,"answer":54},"Why does hepatitis A spread so easily through food and water compared to hepatitis B or C?","HAV has no envelope, just a tough protein capsid that can survive stomach acid, bile, and detergent-like conditions in the gut. Hepatitis B and C are enveloped and far more fragile outside the body, which is why they spread mainly through blood and body fluids rather than contaminated food or water.",{"question":56,"answer":57},"Is a person with hepatitis A most contagious when they look sickest?","No, it's the opposite. Virus shedding in stool peaks in the 1-2 weeks before jaundice appears, and the person typically becomes noncontagious once jaundice is visible, which is part of why outbreaks can spread before anyone realizes there's a problem.",[],[],[61,68,74,79,83,87,92,97,101,105],{"slug":62,"name":63,"description":64,"image":65,"body":66,"postCount":67},"acharya-tankeshwar","Acharya Tankeshwar","Editor-in-chief","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Ftankeshwar-acharya-author-microbeonline.jpg","***Tankeshwar Acharya, MSc (Medical Microbiology)***\n\n*Tankeshwar Acharya is an Assistant Professor in the Department of Microbiology at Patan Academy of Health Sciences (PAHS), Nepal, where he has been teaching and practicing clinical microbiology for over 14 years. He is the founder of Microbe Online, one of the leading free microbiology education resources on the web, covering bacteriology, mycology, parasitology, immunology, and clinical laboratory diagnostics written from direct experience in both the classroom and the diagnostic laboratory.*",433,{"slug":69,"name":39,"description":70,"image":71,"body":72,"postCount":73},"ashma-shrestha","SEO Copywriter and Science Communicator\nKathmandu, Nepal","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Fashma-shrestha.png","Ashma Shrestha holds a Master of Science in Medical Microbiology from the Institute of Science and Technology (IOST), Tribhuvan University, Nepal, where she developed a strong foundation in virology, molecular biology, and diagnostic microbiology.\n\nShe now works as an SEO Copywriter at Resolution Digital, where she combines her scientific training with research-driven content strategy. She is certified in Google Analytics and Google Business Profile (GBP), and brings a data-informed approach to science communication writing content that is not only accurate but structured to reach and serve the students who need it most.\n\nAt microbeonline, Ashma contributes articles primarily in virology and molecular biology, areas she finds most compelling for their mechanistic depth and their growing clinical relevance. Her writing reflects the same standard the site is built on: factual rigor, clear explanation of the *why* behind microbiology concepts, and content that helps students move from memorization to genuine understanding.\n\nShe is passionate about making complex microbiological concepts accessible without sacrificing accuracy; a skill that sits at the intersection of her scientific training and her professional work in content and SEO.",81,{"slug":75,"name":76,"description":77,"image":38,"body":38,"postCount":78},"sushmita-baniya","Sushmita Baniya","Author \u002F Contributor",32,{"slug":80,"name":81,"description":77,"image":38,"body":38,"postCount":82},"samikshya-acharya","Samikshya Acharya",20,{"slug":84,"name":85,"description":77,"image":38,"body":38,"postCount":86},"alisha-tripathi","Alisha Tripathi",6,{"slug":88,"name":89,"description":90,"image":38,"body":38,"postCount":91},"aastha-shrestha","Aastha Shrestha"," Author \u002F Contributor",9,{"slug":93,"name":94,"description":95,"image":38,"body":38,"postCount":96},"guest-author","Guest Author","Guest Author \u002F Contributor",2,{"slug":98,"name":99,"description":77,"image":38,"body":38,"postCount":100},"srijana-khanal","Srijana Khanal",18,{"slug":102,"name":103,"description":95,"image":38,"body":38,"postCount":104},"dr-poonam-acharya","Dr. Poonam Acharya",1,{"slug":106,"name":107,"description":77,"image":38,"body":108,"postCount":109},"nisha-rijal","Nisha Rijal","**Nisha Rijal** is a microbiologist and quality assurance specialist. She served for nearly 12 years as a microbiologist at the National Public Health Laboratory (NPHL), Nepal's national reference laboratory, and continues to work as a consultant microbiologist in international public health organization. ",51]